Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. The company’s ...

Morgan Stanley initiated coverage of Roche (RHHBY) with an Equal Weight rating and CHF 305 price target The firm sees the end of Roche’s earnings downgrade cycle, with a pick up in “high risk ...

UBS upgraded Roche (RHHBY) to Buy from Neutral with a price target of CHF 338, up from CHF 300. The company offers sustainable growth with margin leverage, the analyst tells investors in a ...

"People with Type 1 diabetes now live normal lifespans, and it is crucial to study this population to ensure they receive the best possible care." This research marks the first time the Doctors ...

This trial isn't just about advancing technology - it's a bold step toward transforming diabetes care and uplifting lives.We are committed to creating a fully automated, intelligent insulin ...

To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. For over 125 years, ...

Basel, 04 February 2025 - Roche (SIX: RO, ROG ... macular edema (DME), a leading cause of vision loss in adults with diabetes, affecting more than 29 million adults worldwide.

Basel, 04 February 2025 - Roche ... with diabetes, affecting more than 29 million adults worldwide. 1-3 Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with DME ...

In diagnostics, Roche is providing biomarkers and research assays that will help during drug development, as well as tests to guide treatment decisions in medical care. The healthcare landscape is ...

Following good foot care habits will go a long way toward keeping your feet healthy. Here are a few helpful tips. It’s possible for people with diabetes to perform routine toenail care.